Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Karnes

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Urology|August 30, 2024
Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?Ekamjit S Deol, Vidit Sharma, Anthony E Fadel, et al.
Prostate Cancer and Prostatic Diseases|October 15, 2014
Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient populationS P Kim, C P Gross, M C Smaldone, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2014
Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancerS P Kim, C P Gross, P L Nguyen, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2016
Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional reviewA Leone, B Gershman, K Rotker, et al.
Prostate Cancer and Prostatic Diseases|August 27, 2014
Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomyS B Stewart, J C Cheville, T J Sebo, et al.
European Urology Focus|March 14, 2018
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control StudyT Steuber, C Jilg, P Tennstedt, et al.
British Journal of Anaesthesia|December 19, 2013
Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort studyF Scavonetto, T Y Yeoh, E C Umbreit, et al.
Clinical Genitourinary Cancer|November 26, 2023
Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical CystectomyRebecca A Campbell, Abhinav Khanna, Stephen A Boorjian, et al.
Prostate Cancer and Prostatic Diseases|October 23, 2013
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomyA E Ross, F Y Feng, M Ghadessi, et al.
The Journal of Urology|October 25, 2021
Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional ExperienceAbhinav Khanna, Tanner Miest, Vidit Sharma, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Urology|August 30, 2024
Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?Ekamjit S Deol, Vidit Sharma, Anthony E Fadel, et al.
Prostate Cancer and Prostatic Diseases|October 15, 2014
Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient populationS P Kim, C P Gross, M C Smaldone, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2014
Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancerS P Kim, C P Gross, P L Nguyen, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2016
Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional reviewA Leone, B Gershman, K Rotker, et al.
Prostate Cancer and Prostatic Diseases|August 27, 2014
Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomyS B Stewart, J C Cheville, T J Sebo, et al.
European Urology Focus|March 14, 2018
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control StudyT Steuber, C Jilg, P Tennstedt, et al.
British Journal of Anaesthesia|December 19, 2013
Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort studyF Scavonetto, T Y Yeoh, E C Umbreit, et al.
Clinical Genitourinary Cancer|November 26, 2023
Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical CystectomyRebecca A Campbell, Abhinav Khanna, Stephen A Boorjian, et al.
Prostate Cancer and Prostatic Diseases|October 23, 2013
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomyA E Ross, F Y Feng, M Ghadessi, et al.
The Journal of Urology|October 25, 2021
Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional ExperienceAbhinav Khanna, Tanner Miest, Vidit Sharma, et al.
Pageof 8